Anti-CD38 nanobodies as theranostic agents for multiple myeloma

被引：0
|
作者：
Duray, Elodie [1 ]
Lejeune, Margaux [1 ]
Dumoulin, Mireille [1 ]
D'Huyvetter, Matthias [2 ]
Caers, Jo [3 ]
机构：
[1] ULiege, Liege, Belgium
[2] Vrije Univ Brussel, Brussels, Belgium
[3] CHU Liege, Liege, Belgium
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-044
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [41] The effects of anti-CD38 monoclonal antibody and anti-HI antibody on pretransfusion testing in a patient with multiple myeloma
    Zhu, Zhe
    Hong, Kairui
    Ke, Yefang
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1961 - 1962
  • [42] Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
    Lee, Hyun Tae
    Kim, Yujin
    Park, Ui Beom
    Jeong, Tae Jun
    Lee, Sang Hyung
    Heo, Yong-Seok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 536 : 26 - 31
  • [43] Selinexor containing regimens in patients with multiple myeloma (MM) previously treated with anti-CD38 monoclonal antibodies (αCD38 mAbs).
    Gasparetto, Cristina
    Lipe, Brea
    Tuchman, Sascha
    Bahlis, Nizar J.
    Sutherland, Heather J.
    Rossi, Adriana C.
    Lentzsch, Suzanne
    Baljevic, Muhamed
    Callander, Natalie Scott
    Venner, Christopher P.
    Sebag, Michael
    White, Darrell
    Kotb, Rami
    Chen, Christine
    Biran, Noa
    Madan, Sumit
    LeBlanc, Richard
    DeCastro, Andrew
    Schiller, Gary J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination
    Terpos, Evangelos
    Gavriatopoulou, Maria
    Ntanasis-Stathopoulos, Ioannis
    Briasoulis, Alexandros
    Gumeni, Sentiljana
    Malandrakis, Panagiotis
    Fotiou, Despina
    Papanagnou, Eleni-Dimitra
    Migkou, Magdalini
    Theodorakakou, Foteini
    Roussou, Maria
    Eleutherakis-Papaiakovou, Evangelos
    Kanellias, Nikolaos
    Trougakos, Ioannis
    Kastritis, Efstathios
    Dimopoulos, Meletios-Athanasios
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S104 - S104
  • [45] Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma Immunotherapy
    Malavasi, Fabio
    Faini, Angelo Corso
    CLINICAL CANCER RESEARCH, 2019, 25 (10) : 2946 - 2948
  • [46] Anti-CD38 autoantibodies and diabetes
    Raymondjean, M
    M S-MEDECINE SCIENCES, 1998, 14 (10): : 1132 - 1133
  • [47] Anti-CD38 monoclonal antibody impairs CD34+mobilization and affects clonogenic potential in multiple myeloma patients
    Zappaterra, Arianna
    Civettini, Ivan
    Cafro, Anna Maria
    Pezzetti, Laura
    Pierini, Silvia
    Anghilieri, Michela
    Bellio, Laura
    Bertazzoni, Paola
    Grillo, Giovanni
    Minga, Periana
    Pioltelli, Maria L.
    Ravano, Emanuele
    Sassone, Marianna
    V. Vigano, Clara
    Volpato, Elisabetta B.
    Gambacorti-Passerini, Carlo
    Rossini, Silvano
    Cairoli, Roberto
    Crocchiolo, Roberto
    BLOOD TRANSFUSION, 2024, 22 (04) : 328 - 337
  • [48] SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma
    Kassem, Sahar
    Diallo, Bere K.
    El-Murr, Nizar
    Carrie, Nadege
    Tang, Alexandre
    Fournier, Alain
    Bonnevaux, Helene
    Nicolazzi, Celine
    Cuisinier, Marine
    Arnould, Isabelle
    Sidhu, Sukhvinder S.
    Corre, Jill
    Avet-Loiseau, Herve
    Teillaud, Jean-Luc
    van de Velde, Helgi
    Wiederschain, Dmitri
    Chiron, Marielle
    Martinet, Ludovic
    Virone-Oddos, Angela
    BLOOD, 2022, 139 (08) : 1160 - 1176
  • [49] Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model
    Green, Damian J.
    Orgun, Nural N.
    Hylarides, Mark D.
    Pagel, John M.
    Hamlin, Donald K.
    Wilbur, D. Scott
    Lin, Yukang
    Kenoyer, Amiee L.
    Frayo, Shani L.
    Bensinger, William I.
    Gopal, Ajay K.
    Orozco, Johnnie J.
    Gooley, Theodore A.
    Wood, Brent L.
    Press, Oliver W.
    BLOOD, 2011, 118 (21) : 802 - 803
  • [50] Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma
    Lonial, Sagar
    Bowser, Andrew D.
    Chari, Ajai
    Costello, Caitlin
    Krishnan, Amrita
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 815 - 824
12345